文献速递神经免疫

EB病毒作为多发性硬化病因:预防与治疗机遇

Epstein-Barr virus as a cause of multiple sclerosis: opportunities for prevention and therapy.
PubMed 文献 · Lancet Neurol · 2023-02-07

多发性硬化由遗传与环境因素相互作用所致,来自不同研究领域的证据支持EB病毒(EBV)在其发病中起关键作用。将这一认识转化为临床可行信息,需更好理解EBV与病理生理的关联机制;针对EBV的临床试验和新疫苗为未来治疗与预防带来希望。

要点

  • 多领域证据支持EBV在多发性硬化发病中起关键作用。
  • EBV可能通过自身免疫或抗病毒免疫驱动神经炎症。
  • 针对EBV的临床试验和新型抗EBV疫苗带来治疗与预防希望。

核心结论

  • 来自不同研究领域的证据支持EBV在多发性硬化发病中起关键作用,但需更好理解其与病理生理的关联机制才能转化为临床可行信息。

主要发现

  • 多发性硬化是遗传与环境因素相互作用所致的中枢神经系统慢性炎性疾病。
  • EBV可能通过自身免疫或抗病毒免疫驱动神经炎症,尚待研究澄清。
  • EBV与多发性硬化遗传易感性的交互作用可能解释普遍存在的病毒为何在易感个体中促进免疫功能障碍。
  • 若EBV在驱动疾病活动中也起作用,明确该作用将有助于多发性硬化的诊断、预后和治疗。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Multiple sclerosis is a chronic inflammatory disease of the CNS that results from the interplay between heritable and environmental factors. Mounting evidence from different fields of research supports the pivotal role of the Epstein-Barr virus (EBV) in the development of multiple sclerosis. However, translating this knowledge into clinically actionable information requires a better understanding of the mechanisms linking EBV to pathophysiology. Ongoing research is trying to clarify whether EBV causes neuroinflammation via autoimmunity or antiviral immunity, and if the interaction of EBV with genetic susceptibility to multiple sclerosis can explain why a ubiquitous virus promotes immune dysfunction in susceptible individuals. If EBV also has a role in driving disease activity, the characterisation of this role will help diagnosis, prognosis, and treatment in people with multiple sclerosis. Ongoing clinical trials targeting EBV and new anti-EBV vaccines provide hope for future treatments and preventive interventions.

来源:Lancet Neurol,查看原文。版权归原作者所有。

引用

  1. Aloisi F, Giovannoni G, Salvetti M, et al. Epstein-Barr virus as a cause of multiple sclerosis: opportunities for prevention and therapy. Lancet Neurol. 2023. PMID: 36764322. doi:10.1016/S1474-4422(22)00471-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。